Results 161 to 170 of about 8,585 (230)

The Left Atrial Appendage in Sinus Rhythm and Atrial Fibrillation: From Functional Structure to Potential Thromboembolic Reservoir, Rationale for Medical or Radical Exclusion. [PDF]

J Clin Med
Zeitani J, Likaj E, Nazzaro MS, Dibra A, Sievert K, Sievert H.   +5 more
europepmc   +1 more source

Extracting a Malpositioned Occluder Device Using Endovascular Forceps. [PDF]

JACC Case Rep
Roy S, Bakhshi H, Aziz H, Hasan R.
europepmc   +1 more source

Suspended Lead Suits and Radiation Exposure in Interventional Echocardiographers.

JAMA Netw Open
McNamara DA, Decker JM, McNamara MW, Kenaan MA, Cameron DM, VanOosterhout S, Parker JL, Madder RD.   +7 more
europepmc   +1 more source

3-Year Outcomes From the Amplatzer Amulet Left Atrial Appendage Occluder Randomized Controlled Trial (Amulet IDE)

JACC: Cardiovascular Interventions, 2023
BACKGROUND The Amulet (Abbott) left atrial appendage occluder investigational device exemption trial is the largest randomized trial evaluating the safety and effectiveness of the Amulet left atrial appendage occluder compared with the Watchman 2.5 ...
Vijendra Swarup, James Hermiller, Mohamad Alkhouli   +2 more
exaly   +3 more sources

Amulet

Notes and Queries
Teardrop shaped amulet, one suspension loop, one suspension ring, inscribed both sidesDigital ...
Unknown Artist
core   +10 more sources

Left atrial appendage sealing performance of the Amplatzer Amulet and Watchman FLX device

Journal of Interventional Cardiac Electrophysiology, 2022
Background The left atrial appendage (LAA) sealing properties of the Amplatzer Amulet and Watchman FLX devices were compared using cardiac computed tomography (CT) follow-up. Methods Single-center cohort study of patients undergoing LAAO between 2017 and
Kasper Korsholm, Anders Kramer, Asger Andersen   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

5-Year Results From the AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial

Journal of the American College of Cardiology
BACKGROUND The Amulet IDE trial (AMPLATZER Amulet Left Atrial Appendage Occluder [LAAO] Investigational Device Exemption [IDE] Trial) evaluated the safety and effectiveness of the Amulet occluder (Abbott) in patients with nonvalvular atrial fibrillation.
Vijendra Swarup, James Hermiller
exaly   +2 more sources

Outcomes of the roll-in cohort of the Amulet IDE trial of left atrial appendage occlusion

Heart Rhythm O2, 2022
Background Left atrial appendage (LAA) occlusion is an alternative therapy to oral anticoagulants to reduce stroke risk in patients with nonvalvular atrial fibrillation (NVAF).
Vijendra Swarup, James Hermiller, Brijeshwar Maini   +2 more
exaly   +2 more sources